Biljana Stankovic
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 28, 2026
Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis.Biljana Stankovic, Mihajlo Stasuk, Vladimir Gasic
|Jan 10, 2026
Correction: Tosic et al. High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia. Int. J. Mol. Sci. 2025, 26, 1153.Natasa Tosic, Kristina Tomic Vujovic, Vojin Vukovic
|Feb 13, 2025
High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia.Natasa Tosic, Kristina Tomic Vujovic, Vojin Vukovic
|Aug 27, 2024
Psychological Distress Is Associated With Inflammatory Bowel Disease Manifestation and Mucosal Inflammation.Sanja Dragasevic, Biljana Stankovic, Nikola Kotur
|Sep 28, 2021
Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications.Biljana Stankovic, Nikola Kotur, Gordana Nikcevic
|Apr 30, 2020
Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment.Nikola Kotur, Jelena Lazic, Bojan Ristivojevic
Pageof 1
Frequent Collaborators
5 joint publications
Nikola Kotur
2 joint publications
Natasa Tosic
2 joint publications
Kristina Tomic Vujovic
2 joint publications
Irena Marjanovic
2 joint publications
Darko Antic
2 joint publications
Jelena Ivanovic
1 joint publications
Branka Zukic
1 joint publications
Sanja Dragasevic
1 joint publications
Tamara Bibic
1 joint publications
Bojan Ristivojevic
